Name: Rob van den Brom

Country: Netherlands


University Medical Center Groningen

Email: Send an Email


Hanzeplein 1
9700 RB  Groningen
the Netherlands

Research Interests:

  • melanoma
  • renal cell carcinoma
  • GIST
  • immune checkpoint inhibitors



  1. Systemic vasculitis developed after immune checkpoint inhibition.
  2. Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.
  3. Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
  4. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
  5. Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
  6. Effect of vemurafenib on a V600R melanoma brain metastasis.
  7. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
  8. Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer.